Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

183 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Low- versus standard-dose post-transplant cyclophosphamide as GVHD prophylaxis for haploidentical transplantation.
Fuji S, Sugita J, Najima Y, Konishi T, Tanaka T, Ohigashi H, Eto T, Nagafuji K, Hiramoto N, Matsuoka KI, Maruyama Y, Ota S, Ishikawa J, Kawakita T, Akasaka T, Kamimura T, Hino M, Fukuda T, Atsuta Y, Yakushijin K. Fuji S, et al. Among authors: yakushijin k. Br J Haematol. 2024 Mar;204(3):959-966. doi: 10.1111/bjh.19228. Epub 2023 Nov 30. Br J Haematol. 2024. PMID: 38037468
Impact of stem cell source and conditioning regimen on erythrocyte recovery kinetics after allogeneic haematopoietic stem cell transplantation from an ABO-incompatible donor.
Kanda Y, Tanosaki R, Nakai K, Saito T, Ohnishi M, Niiya H, Chizuka A, Yakushijin K, Urahama N, Ueda K, Iijima K, Ando T, Matsubara H, Kami M, Makimoto A, Kobayashi Y, Tobinai K, Mineishi S, Takaue Y. Kanda Y, et al. Among authors: yakushijin k. Br J Haematol. 2002 Jul;118(1):128-31. doi: 10.1046/j.1365-2141.2002.03693.x. Br J Haematol. 2002. PMID: 12100136 Free article.
Feasibility of reduced-intensity cord blood transplantation as salvage therapy for graft failure: results of a nationwide survey of adult patients.
Waki F, Masuoka K, Fukuda T, Kanda Y, Nakamae M, Yakushijin K, Togami K, Nishiwaki K, Ueda Y, Kawano F, Kasai M, Nagafuji K, Hagihara M, Hatanaka K, Taniwaki M, Maeda Y, Shirafuji N, Mori T, Utsunomiya A, Eto T, Nakagawa H, Murata M, Uchida T, Iida H, Yakushiji K, Yamashita T, Wake A, Takahashi S, Takaue Y, Taniguchi S. Waki F, et al. Among authors: yakushijin k. Biol Blood Marrow Transplant. 2011 Jun;17(6):841-51. doi: 10.1016/j.bbmt.2010.09.005. Epub 2010 Sep 16. Biol Blood Marrow Transplant. 2011. PMID: 20849969 Free article.
Comparison of outcomes after allogeneic hematopoietic stem cell transplantation in patients with follicular lymphoma, diffuse large B-cell lymphoma associated with follicular lymphoma, or de novo diffuse large B-cell lymphoma.
Tada K, Kim SW, Asakura Y, Hiramoto N, Yakushijin K, Kurosawa S, Tajima K, Mori S, Heike Y, Tanosaki R, Maeshima AM, Taniguchi H, Furuta K, Kagami Y, Matsuno Y, Tobinai K, Takaue Y, Fukuda T. Tada K, et al. Among authors: yakushijin k. Am J Hematol. 2012 Aug;87(8):770-5. doi: 10.1002/ajh.23246. Epub 2012 May 28. Am J Hematol. 2012. PMID: 22641292 Free article. Clinical Trial.
Changes in incidence and causes of non-relapse mortality after allogeneic hematopoietic cell transplantation in patients with acute leukemia/myelodysplastic syndrome: an analysis of the Japan Transplant Outcome Registry.
Kurosawa S, Yakushijin K, Yamaguchi T, Atsuta Y, Nagamura-Inoue T, Akiyama H, Taniguchi S, Miyamura K, Takahashi S, Eto T, Ogawa H, Kurokawa M, Tanaka J, Kawa K, Kato K, Suzuki R, Morishima Y, Sakamaki H, Fukuda T. Kurosawa S, et al. Among authors: yakushijin k. Bone Marrow Transplant. 2013 Apr;48(4):529-36. doi: 10.1038/bmt.2012.172. Epub 2012 Sep 10. Bone Marrow Transplant. 2013. PMID: 22964595 Clinical Trial.
Impact of hepatitis C virus infection on clinical outcome in recipients after allogeneic hematopoietic cell transplantation.
Nakasone H, Kurosawa S, Yakushijin K, Taniguchi S, Murata M, Ikegame K, Kobayashi T, Eto T, Miyamura K, Sakamaki H, Morishima Y, Nagamura T, Suzuki R, Fukuda T. Nakasone H, et al. Among authors: yakushijin k. Am J Hematol. 2013 Jun;88(6):477-84. doi: 10.1002/ajh.23436. Epub 2013 May 13. Am J Hematol. 2013. PMID: 23483626 Free article.
Recent decrease in non-relapse mortality due to GVHD and infection after allogeneic hematopoietic cell transplantation in non-remission acute leukemia.
Kurosawa S, Yakushijin K, Yamaguchi T, Atsuta Y, Nagamura-Inoue T, Akiyama H, Taniguchi S, Miyamura K, Takahashi S, Eto T, Ogawa H, Kurokawa M, Tanaka J, Kawa K, Kato K, Suzuki R, Morishima Y, Sakamaki H, Fukuda T. Kurosawa S, et al. Among authors: yakushijin k. Bone Marrow Transplant. 2013 Sep;48(9):1198-204. doi: 10.1038/bmt.2013.42. Epub 2013 Apr 8. Bone Marrow Transplant. 2013. PMID: 23562971
Reduced-intensity conditioning regimen with low-dose ATG-F for unrelated bone marrow transplant is associated with lower non-relapse mortality than a regimen with low-dose TBI: a single-center retrospective analysis of 103 cases.
Fuji S, Ueno N, Hiramoto N, Asakura Y, Yakushijin K, Kamiyama Y, Kurosawa S, Kim SW, Heike Y, Yamashita T, Fukuda T. Fuji S, et al. Among authors: yakushijin k. Int J Hematol. 2013 Nov;98(5):608-14. doi: 10.1007/s12185-013-1449-y. Epub 2013 Oct 4. Int J Hematol. 2013. PMID: 24092050
183 results